This formulation combines Cagrilintide (5mg), a long-acting amylin-pathway analogue, with GLP-1S (5mg), a GLP-1 receptor agonist widely studied for metabolic and appetite-related signaling. Together, these peptides are frequently used in scientific research exploring dual-pathway regulation, energy-balance modeling, and peptide-hormone interactions.
Researchers employ this combination in in-vitro studies to evaluate how amylin-receptor and GLP-1-receptor activation may influence satiety signaling, gastric-emptying pathways, glucose-related feedback loops, and overlapping endocrine mechanisms. This blend provides an effective model for studying complex multi-agonist peptide behavior and its impact on metabolic regulation systems.
Explore related GLP-1 series products: GLP-1S, GLP-1T, and GLP-1R.
Components:
-
Cagrilintide: 5mg
-
GLP-1S: 5mg
Form: Lyophilized powder
Purity: ≥99% (HPLC verified)
Storage: Store at −20°C, protected from light and moisture.




